Onkologie. 2012:6(5):247-251

Modern technologies in head and neck cancer radiotherapy

Milan Vošmik, Miroslav Hodek, Igor Sirák, Jan Jansa, Linda Kašaová, Petr Paluska
Klinika onkologie a radioterapie, Fakultní nemocnice Hradec Králové

Radiotherapy represents an important treatment modality in head and neck cancer. Recent technological advances in radiotherapy treatment

planning and dose delivery make possible more precise delivery of radiation to target volumes while sparing adjacent healthy tissues

and organs at risk. Magnetic resonance imaging or positron emission tomography-based planning allow better delineation of

gross tumor volume, intensity-modulated radiotherapy, proton therapy or stereotactic radiotherapy offer higher conformality in dose

delivery, image-guided radiotherapy enables a reduction of set-up margin. The goal of all new technologies in radiotherapy of head and

neck cancer is a reduction of radiotherapy-related toxicity and, in this way, an improvement of clinical results.

Keywords: head and neck cancer, intensity-modulated radiotherapy, image-guided radiotherapy, adaptive radiotherapy

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vošmik M, Hodek M, Sirák I, Jansa J, Kašaová L, Paluska P. Modern technologies in head and neck cancer radiotherapy. Onkologie. 2012;6(5):247-251.
Download citation

References

  1. Hermans R, Feron M, Bellon E, et al. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys 1998; 40: 553-557. Go to original source... Go to PubMed...
  2. Nuyts S. Defining the target for radiotherapy of head and neck cancer. Cancer Imaging 2007; 7(Suppl A): 50-S55. Go to original source... Go to PubMed...
  3. Troost EG, Schinagl DA, Bussink J, Oyen WJ, Kaanders JH. Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours. Radiother Oncol 2010; 96: 328-334. Go to original source... Go to PubMed...
  4. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004; 233: 93-100. Go to original source... Go to PubMed...
  5. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003; 57: 61-70. Go to original source... Go to PubMed...
  6. Nutting CM, Morden JP, Harrington KJ, et al. Parotid sparing intensity modulated versus conventional radiotherapy in head and neckcancer (PARSPORT): a phase 3 multicentre randomised controlled trial, Lancet Oncol 2011; 12: 127-136. Go to original source... Go to PubMed...
  7. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007; 25: 4873-4879. Go to original source... Go to PubMed...
  8. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006; 66: 981-991. Go to original source... Go to PubMed...
  9. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004; 60: 1425-1439. Go to original source... Go to PubMed...
  10. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-1298. Go to original source... Go to PubMed...
  11. Roe JW, Carding PN, Dwivedi RC, et al. Swallowing outcomes following intensity modulated radiation therapy (IMRT) for head&neck cancer - a systematic review. Oral Oncol 2010; 46: 727-733. Go to original source... Go to PubMed...
  12. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000; 46: 195-205. Go to original source... Go to PubMed...
  13. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000; 46: 619-630. Go to original source... Go to PubMed...
  14. Gilbeau L, Octave-Prignot M, Loncol T, et al. Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. Radiother Oncol 2001; 58: 155-162. Go to original source... Go to PubMed...
  15. Chen AM, Farwell DG, Luu Q, Donald PJ, Perks J, Purdy JA. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance? Int J Radiat Oncol Biol Phys 2011; 81: 943-949. Go to original source... Go to PubMed...
  16. Schwartz DL, Dong L. Adaptive radiation therapy for head and neck cancer-can an old goal evolve into a new standard? J Oncol 2011: pii: 690595. Go to original source... Go to PubMed...
  17. Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007; 85: 74-82. Go to original source... Go to PubMed...
  18. Ahunbay EE, Peng C, Godley A, Schultz C, Li XA. An on-line replanning method for head and neck adaptive radiotherapy. Med Phys 2009; 36: 4776-4790. Go to original source... Go to PubMed...
  19. Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys 2011; 79: 985-997. Go to original source... Go to PubMed...
  20. Wegner RE, Rodriguez KD, Heron DE, Hirsch BE, Ferris RL, Burton SA. Linac-based stereotactic body radiation therapy for treatment of glomus jugulare tumors. Radiother Oncol 2010; 97: 395-398. Go to original source... Go to PubMed...
  21. Comet B, Kramar A, Faivre-Pierret M, et al. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 2012; 84: 203-209. Go to original source... Go to PubMed...
  22. Lee DS, Kim YS, Cheon JS, et al. Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment. Radiat Oncol 2012; 7: 85. Go to original source... Go to PubMed...
  23. Weber DC, Chan AW, Lessell S, et al. Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons. Radiother Oncol 2006; 81: 243-249. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.